Investig Clin Urol.  2018 Jul;59(4):280-281. 10.4111/icu.2018.59.4.280.

Letter to the editor: Safety and feasibility of platelet rich fibrin matrix injections for treatment of common urologic conditions

• Spartalis
• Tsilimigras DI
• Sfoungaristos S

• KMID: 2414762
• DOI: http://doi.org/10.4111/icu.2018.59.4.280

Abstract

No abstract available.

MeSH Terms

Blood Platelets*
Fibrin*
Fibrin

Reference

1. Matz EL, Pearlman AM, Terlecki RP. Safety and feasibility of platelet rich fibrin matrix injections for treatment of common urologic conditions. Investig Clin Urol. 2018; 59:61–65.

2. Wu YN, Wu CC, Sheu MT, Chen KC, Ho HO, Chiang HS. Optimization of platelet-rich plasma and its effects on the recovery of erectile function after bilateral cavernous nerve injury in a rat model. J Tissue Eng Regen Med. 2016; 10:E294–E304. PMID: 23950105.

3. Spartalis ED, Tomos P, Dimitroulis D, Kouraklis G. Platelet-rich plasma in surgical oncology. Surg Innov. 2014; 21:441. PMID: 24496102.

4. Spartalis E, Moris D, Dimitroulis D, Tomos P. Postresectional airway fistula occlusion via stem-cell transplantation: is it oncologically safe. Ann Thorac Surg. 2015; 100:2413–2414.

5. Spartalis E, Tomos P, Konofaos P, Karagkiouzis G, Levidou G, Kavantzas N, et al. The effect of autologous platelet-rich plasma on bronchial stump tissue granulation after pneumonectomy: experimental study. ISRN Surg. 2013; 12. 16. [Epub]. DOI: 10.1155/2013/864350.

6. Spartalis ED, Tomos P, Konofaos P, Dimitroulis D, Kouraklis G. Breast reconstruction with autologous fat graft; does platelet-rich plasma affect patient's survival? Int J Clin Exp Med. 2014; 7:329–330. PMID: 24482728.